Citicoline Monosodium Salt
CDP Choline Sodium Salt
- CAS
- 33818-15-4
- EC
- 251-689-1
- Sectors
- Pharma & Healthcare, Nutraceuticals & Supplements
Citicoline Monosodium Salt (CAS 33818-15-4) is a synthetically produced intermediate for phospholipid biosynthesis, supplied as a white solid powder and used in pharmaceutical and nutraceutical products covering memory loss, stroke, dementia and head trauma. It acts as a biosynthetic intermediate for phospholipids, stable under ambient conditions, and produced synthetically.
Typical Properties
| Molecular formula | C14H26N4O11P2.Na |
|---|---|
| Molecular weight | 510.31 g/mol |
| Form | solid |
| Color | white |
| Melting point | 259-268°C (dec.) |
| Water solubility | Soluble in water (100 mg/ml). |
| HS code | 29349990 |
| Grades available | Pharma Grade |
Typical literature values for identification; lot-specific results are stated on the certificate of analysis (COA) and the safety data sheet (SDS) that accompany every delivery.
Citicoline Monosodium Salt
Applications
Used in pharmaceuticals to treat memory loss, stroke, dementia, and head trauma; as a cerebral vasodilator, inhibits PLA2, and in supplements for cognitive enhancement.
Safety & Risks
Low toxicity; may cause mild side effects like nausea. Stable; avoid incompatible materials. Use as a pharmaceutical secondary standard; PPE recommended.
Packaging
In glass vials or 25kg drums; store sealed; dispose per pharmaceutical guidelines, rinsing for recycling.